Nimesh Shah

Nimesh is a co-founder and current board member of Zyga Technology and a board member of Benvenue Medical, Cotera, Fractyl Laboratories, Miramar Labs, Sequent Medical, and Twelve, and is a board observer at ReVision Optics. He is also involved with The Foundry, a medical devices incubator. He had previously been involved as an observer with REVA Medical, Tandem Diabetes Care and Zogenix, all of which completed successful public offerings. Prior to Domain, Nimesh was a part of the investment team at venture firm Cutlass Capital where he was involved with that firm’s investments in Apneon, GI Dynamics, Titan Health, and TranS1. Previous to that, Nimesh worked at Alex. Brown & Sons (now Deutsche Bank) serving as a member of the medical device equity research team. Nimesh received his B.S. in biomedical engineering from Johns Hopkins University. While in school, he worked supporting the investment team at Alex. Brown Capital Advisory & Trust. He also spent time at Johns Hopkins Hospital involved in a project that aimed to map the functional areas of the brain. He currently serves on the Dean's Leadership Council for the UCSD School of Biological Sciences and as a board member for the San Diego Venture Group.